Loading Events

« All Events

  • This event has passed.

Advances in Cell and Tissue Culture 2018

May 21 - May 23


CLICK HERE TO FIND OUT MORE

ADVANCES IN CELL AND TISSUE CULTURE 2018

21-23 May 2018, Cardiff, Wales

ACTC 2018 aims to create an interdisciplinary forum in which over 100 industry and academic researchers, working in cell culture can exchange knowledge, promote their activities and set up new collaborative projects.

The programme includes:

  • Advanced Cell Culture: 3D, Fluid Flow and Co-culture
    • Keynote Speakers:
      • Dr Dominic Williams (AstraZeneca)
      • Dr Murat Cirit (Massachusetts Institute of Technology
      • Dr Paul Walker (Cyprotex)
    • Chairs:
      • Professor Trevor Dale (Cardiff University)
      • Dr Doris Wilfingseder (University of Innsbruck)
  • In Vitro Models for Animal Replacement
    • Keynote Speaker: Professor Tommy B Andersson (AstraZeneca)
    • Chair: Dr Gerry Kenna (Safer Medicines Trust)
  • In Vitro Models for the Study of Neurological Diseases
    • Keynote Speaker: Professor Geoff Pilkington (University of Portsmouth)
    • Chair: Professor Roxana O Carare (University of Southampton)
  • Stem Cells: Developing Off the Shelf Therapeutics
    • Keynote Speaker: Dr Hassan Rashidi (University of Edinburgh)
    • Chair: Dr Pascale Guillot (UCL)
  • Creating More Realistic Gut Models
    • Keynote Speaker: Christophe Lacroix (ETH Zurich)
    • Chair: Professor Julian Marchesi (Imperial College London & Cardiff University)

For more information please visit www.actc2018.com

For all enquiries contact info@actc2018.com

CLICK HERE TO FIND OUT MORE

Details

Start:
May 21
End:
May 23
Event Category:
Website:
http://actc2018.com/

Organizer

ACTC
Phone:
+44 (0)1709 361 241
Email:
info@actc2018.com

Venue

Cardiff School of Biosciences
The Sir Martin Evans Building, Museum Ave
Cardiff, CF10 3AX United Kingdom
+ Google Map

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.